Cargando…
Use of COVID-19 Convalescent Plasma for Treatment of Symptomatic SARS-CoV-2 Infection at a Children’s Hospital: A Contribution to a Still Inadequate Body of Evidence
Data on COVID-19 convalescent plasma (CCP) safety and efficacy in children and young adults are limited. This single-center prospective, open-label trial evaluates CCP safety, neutralizing antibody kinetics, and outcomes in children and young adults with moderate/severe COVID-19 (April 2020–March 20...
Autores principales: | Arrieta, Antonio, Galvis, Alvaro E., Osborne, Stephanie, Morphew, Tricia, Imfeld, Karen, Enriquez, Claudia, Hoang, Janet, Swearingen, Marcia, Nieves, Delma J., Ashouri, Negar, Singh, Jasjit, Nugent, Diane |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9955755/ https://www.ncbi.nlm.nih.gov/pubmed/36832478 http://dx.doi.org/10.3390/children10020350 |
Ejemplares similares
-
1418. Pharmacokinetics (PK) and Toxicity of Intravenous Amikacin (AMK) Dosed Three Times a Week (TIW) for Treatment of Disseminated Mycobacterium abscessus Infection in Children
por: Tran, M Tuan, et al.
Publicado: (2018) -
Clofazimine for Treatment of Mycobacterium abscessus Infections in Children
por: Adler-Shohet, Felice C, et al.
Publicado: (2017) -
1675. Community Acquired Serious Bacterial Infections in Pediatric Patients Before and After COVID: Could Masks Save Lives?
por: Arrieta, Antonio C, et al.
Publicado: (2023) -
926. Outbreak of Invasive Nontuberculous Mycobacterium (NTM) Infections Associated With a Pediatric Dental Practice
por: Singh, Jasjit, et al.
Publicado: (2018) -
1432. County-Wide Pediatric IPD Experience Following Prevnar 13 Implementation
por: Nieves, Delma, et al.
Publicado: (2018)